Carilyn Ellis1, William Hoffman2, Sarah Jaehnert3, Jane Plagge4, Jennifer M Loftis5, Daniel Schwartz5, Marilyn Huckans6. 1. Research and Development Service, Portland VA Medical Center, Portland, Oregon; Behavioral Health & Clinical Neurosciences Division, Portland VA Medical Center, Portland, Oregon; Methamphetamine Abuse Research Center, Oregon Health & Science University, Portland, Oregon; Doctor of Psychology Program, George Fox University, Newberg, Oregon. 2. Research and Development Service, Portland VA Medical Center, Portland, Oregon; Behavioral Health & Clinical Neurosciences Division, Portland VA Medical Center, Portland, Oregon; Department of Psychiatry, School of Medicine, Oregon Health & Science University, Portland, Oregon; Methamphetamine Abuse Research Center, Oregon Health & Science University, Portland, Oregon; Department of Behavioral Neuroscience, Oregon Health & Science University, Portland OR. 3. Research and Development Service, Portland VA Medical Center, Portland, Oregon; Behavioral Health & Clinical Neurosciences Division, Portland VA Medical Center, Portland, Oregon; Methamphetamine Abuse Research Center, Oregon Health & Science University, Portland, Oregon; School of Professional Psychology, Pacific University, Hillsboro, Oregon. 4. Behavioral Health & Clinical Neurosciences Division, Portland VA Medical Center, Portland, Oregon. 5. Research and Development Service, Portland VA Medical Center, Portland, Oregon; Department of Psychiatry, School of Medicine, Oregon Health & Science University, Portland, Oregon; Methamphetamine Abuse Research Center, Oregon Health & Science University, Portland, Oregon. 6. Research and Development Service, Portland VA Medical Center, Portland, Oregon; Department of Behavioral Neuroscience, Oregon Health & Science University, Portland OR; Behavioral Health & Clinical Neurosciences Division, Portland VA Medical Center, Portland, Oregon; Department of Psychiatry, School of Medicine, Oregon Health & Science University, Portland, Oregon; Methamphetamine Abuse Research Center, Oregon Health & Science University, Portland, Oregon.
Abstract
OBJECTIVES: Compared with non-addicted controls (CTLs), adults in remission from methamphetamine addiction (MA-REM) evidence impairments on objective measures of executive functioning and impulsivity. METHODS: To evaluate the impact of these impairments in MA-REM adults, demographically matched groups (MA-REM, n=30; CTLs, n=24) completed objective and self-report measures of executive functioning and impulsivity. RESULTS: MA-REM adults demonstrated significantly (p < 0.050) greater objective and subjective problems with executive functioning and impulsivity. CONCLUSIONS: These results suggest that adults in MA-REM are aware of their deficits and that these deficits have significant impact in everyday life.
OBJECTIVES: Compared with non-addicted controls (CTLs), adults in remission from methamphetamine addiction (MA-REM) evidence impairments on objective measures of executive functioning and impulsivity. METHODS: To evaluate the impact of these impairments in MA-REM adults, demographically matched groups (MA-REM, n=30; CTLs, n=24) completed objective and self-report measures of executive functioning and impulsivity. RESULTS: MA-REM adults demonstrated significantly (p < 0.050) greater objective and subjective problems with executive functioning and impulsivity. CONCLUSIONS: These results suggest that adults in MA-REM are aware of their deficits and that these deficits have significant impact in everyday life.
Authors: Maria Jose Fernández-Serrano; Miguel Pérez-García; Antonio Verdejo-García Journal: Neurosci Biobehav Rev Date: 2010-05-06 Impact factor: 8.989
Authors: J Cobb Scott; Steven Paul Woods; Georg E Matt; Rachel A Meyer; Robert K Heaton; J Hampton Atkinson; Igor Grant Journal: Neuropsychol Rev Date: 2007-09 Impact factor: 7.444
Authors: William F Hoffman; Meredith Moore; Raymond Templin; Bentson McFarland; Robert J Hitzemann; Suzanne H Mitchell Journal: Psychopharmacology (Berl) Date: 2006-08-17 Impact factor: 4.530
Authors: Marilyn Huckans; Stephen Boyd; Grant Moncrief; Nathan Hantke; Bethany Winters; Kate Shirley; Emily Sano; Holly McCready; Laura Dennis; Milky Kohno; William Hoffman; Jennifer M Loftis Journal: J Clin Exp Neuropsychol Date: 2021-10-06 Impact factor: 2.283
Authors: Liana Basova; Alexander Lindsey; Anne Marie McGovern; Ronald J Ellis; Maria Cecilia Garibaldi Marcondes Journal: Viruses Date: 2021-03-24 Impact factor: 5.048